Skip to content

Post Holdings

US · POST #2442 by market cap Listed 1970
72.54 -0.78 -1.06%
Live - 5344 symbols - heartbeat 547s ago · 2026-10-07 19:54
After-hours 72.54 0.00%
Market cap
3.19B
P/B
1.04
EPS
5.51
Reader sentiment Are you bullish or bearish on POST?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Company notice
    Asnova Companies: Statutory Post-Transfer Disclosure Documents (ASNOVA Co., Ltd.)
    JPX · 2026/10/5
  • Led by an industry legend, Chervon Holdings bucked the market trend to post strong gains.
    HK MoneyClub · 2026/10/5
  • Rating change
    Research Report Highlights | CICC: Bosideng's terminal retail sales continued to post steady growth in the first half of the fiscal year, maintaining an "Outperform" rating.
    Gelonghui Finance · 2026/9/23
  • Company notice
    Japan Creative Platform Group: Statutory Post-Event Disclosure Document (Share Exchange) (Metal Creation Co., Ltd.)
    JPX · 2026/10/2
  • Rating change
    JAPAN POST INSURANCE Co., Ltd. (7181) Receives a Hold From Mizuho Securities
    TipRanks · 2026/9/10
  • Dow Jones Top Company Headlines at 1 PM ET: Paramount Names Leadership Team for Combined Entity Post $81 Billion Warner Deal | Schneider ...
    Dow Jones · 2026/10/6
  • Rating change
    EVE Energy (300014) 2026 Interim Report Commentary: Power and energy storage shipments continue to post strong growth, with profitability showing marginal improvement.
    China Securities Co., Ltd. · 2026/9/1
  • Company notice
    Infonet Group: Statutory Post-Disclosure Documents (Absorption-Type Corporate Split) (Infonet Co., Ltd.)
    JPX · 2026/10/6
  • Company notice
    Japan Creative Platform Group: Statutory Post-Transaction Disclosure Document (Share Exchange) (City Road Co., Ltd.)
    JPX · 2026/10/2
  • SanBio enters the rankings as the first post-marketing administration of "ACUOG Intracerebral Transplantation Injection" is carried out.
    Fisco Japan · 2026/10/6
  • Wells Fargo Maintains Post Holdings(POST.US) With Hold Rating, Cuts Target Price to $79
    Market Newswire · 2026/10/5
  • Rating change
    Ma Yinglong (600993): In the first half of 2026, its core anorectal business remained solid, while its greater health segment continued to post robust growth.
    Huaxing Securities · 2026/9/2
  • Rating change
    Goldman Sachs Maintains JAPAN POST HLDGS CO LTD(JPHLF.US) With Buy Rating, Cuts Target Price to $17.25
    Market Newswire · 2026/9/15
  • Company notice
    Aflac Inc | 4: Statement of changes in beneficial ownership of securities-10% Owner Japan Post Holdings Co., Ltd.
    SEC · 2026/10/6
  • Rating change
    Analyst Maintains Buy on IX Biopharma, Sees Post-FY26 Transition Driving Strong FY27+ Rebound and Keeps DCF-Based S$1.00 Target Price
    TipRanks · 2026/9/1
  • Rating change
    Longfor Group (00960.HK): Non‑development businesses post steady growth; ongoing debt reduction strengthens financial resilience.
    Changjiang Securities · 2026/9/1
  • JPMorgan says the South Korean stock market is poised to steadily catch up with the post-AI recovery rally.
    Latest · 2026/10/6
  • Rating change
    Ruoyuchen (003010): First-half net profit rose 132% year-on-year, exceeding expectations, with its own brands continuing to post strong growth.
    CICC · 2026/8/31
  • Rating change
    Research Report Spotlight | China Post Securities: Initiates coverage of Sihui Fushi with a "Buy" rating, citing AI‑driven product momentum and an imminent earnings inflection point.
    Gelonghui Finance · 2026/9/18
  • Rating change
    Hangzhou Oxygen Co., Ltd. (002430): Double-digit earnings growth in the first half of 2026; gas sales continue to post strong year-on-year expansion – Industrial Gases Series Report
    中信建投证券 · 2026/8/31
  • Company notice
    Watanabe Sato: Statutory Post-Event Disclosure Documents (Merger) (SW Techno Co., Ltd.)
    JPX · 2026/10/2

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.